1.Application Practice of Establishing Temporary Drug Purchase Approval Function of Hospital in Office Au-tomation System
Yingjun LIU ; Huizhen WU ; Jing AN ; Xudong ZHANG ; Bingnan REN ; Haojing SONG ; Xuran ZHI ; Zhanjun DONG
China Pharmacy 2017;28(10):1372-1375
OBJECTIVE:To improve the hospital workflow and efficiency in temporary drug purchase approval process. METHODS:The approval function for temporary drug purchase was introduced into office automation(OA)system in our hospi-tal,and the effects were evaluated. RESULTS:According to ensuring the administrative approval process,system function permis-sion assignment and approval process design in temporary drug purchase in our hospital,functions for approving temporary drug purchase were established in OA system. It achieved convenient,efficient,timely,networking and paperless approval work,as well as standardized record,checking out at any time and automatic statistics for drug purchase. CONCLUSIONS:Introducing tem-porary drug purchase approval function into hospital OA system can simplify workflow,provide better service for clinic,and pro-mote development of hospital pharmacy management.
2.Application Effects of DS8000 Intelligent Sorting System in the PIVAS of Our Hospital
Yufei LIAN ; Qing SHANG ; Baojing DUAN ; Guoxun PANG ; Bingnan REN ; Gexi CAO ; Zhanjun DONG
China Pharmacy 2017;28(7):933-937
OBJECTIVE:To improve the automation and information level of Pharmacy intravenous admixture service (PIV-AS),and provide reference for the PIVAS development. METHODS:Related functions of DS8000 intelligent sorting system and its effect of PIVAS were introduced;work environment,workflow,work efficiency,labor intensity and sorting error before and af-ter the system application were compared. RESULTS:The application of intelligent sorting system achieved the automation of multi-ple links including reviewing,sorting,automatically counting,automatically generating hand-over lists of departments,statistical inquiring for related information in finished soft bag infusion sorting. Compared with manual sorting,it only covered less area, working environment was neat and orderly,workflow links was reduced (6 vs. 10),work time was shortened (average time for sorting per bag of infusion 13.53 s vs. 3.11 s),labor intensity was decreased,and work error rate was reduced (0.128‰ vs. 0.013‰);meanwhile,it improved the management for shading drugs,and achieved data analysis of PIVAS and management infor-mation. CONCLUSIONS:The application of DS8000 intelligent sorting system has improved the automation and information of PI-VAS,and promoted the construction and development of PIVAS.
3.Comparison of Volume-based Procurement and Innovator Antihypertensive Drugs Based on Digital Pharmaceutical Model
Xiao LI ; Gexi CAO ; Bingnan REN ; Yue ZHAO ; Zhanjun DONG
Herald of Medicine 2023;42(12):1900-1908,后插1
Objective To comprehensively assess the strengths and weaknesses of the 24 antihypertensive drugs procured as Volume-based Procurement(VBP)and innovator drugs by using quantitative evaluation system,and to provide a reference for doctors and patients in medication guidance and pharmaceutical decision-making.Methods The Quantitative Evaluation Criteria in the"Quick Guide to Drug Evaluation and Selection in Chinese Medical Institutions"were refined and optimized.The 24 selected VBP and innovator antihypertensive drugs were quantitatively evaluated according to the optimized quantitative evaluation system with the help of Chinese and English databases such as China Knowledge Network,Wanfang data,Wipunet,Embased,PubMed,and Metstr,as well as guideline search tools such as Meikang MCDEX,Drugwise Data,Up To Date,Medical Pulse and other databases etc.Results Among the 24 antihypertensive drugs,only four innovator drug evaluation scores were higher than those of drugs selected as VBP,namely felodipine tablets,Fosinopril sodium tablets,indapamide extended-release capsules,Irbesartan hydrochlorothiazide tablets.there were five main differences in the evaluation scores,namely economy,consistency evaluation,drug expiry date,global use,and the status of manufacturing enterprises.It was found that 83%of the VBP drugs had higher evaluation scores than those of the innovator drugs.The economic score of the innovator drug was low,and the difference in the scores was between 1-11 points.Conclusion By using the quantitative evaluation system to evaluate the antihypertensive drugs,the advantages and disadvantages of the innovator and VBP antihypertensive drugs can be assessed comprehensively,and the digital characteristics of antihypertensive drugs can be given,and the evaluation score can provide the reference basis for the guidance and decision-making of medication for doctors and patients.
4.Effect of Myod1 on proliferation and apoptosis of oxygen-glucose-deprived SHSY5Y cells by regulating lncRNA SNHG15 and miR-24-3p
Fangchao JI ; Chenxin ZHANG ; Zhanjun REN ; Yunzhi PAN ; Qi LU ; Xingyuan SUN
Journal of Jilin University(Medicine Edition) 2024;50(4):989-999
Objective:To investigate the effect of myogenic differentiation protein 1(Myod1)on the proliferation inhibition and apoptosis of the SH-SY5Y cells induced by oxygen-glucose deprivation(OGD),and to elucidate its mechanism.Methods:Real-time quantitative fluorescence PCR(RT-qPCR)method was used to detect the mRNA levels of Myod1 and long non-coding RNA(lncRNA)small nucleolar RNA host gene 15(SNHG15)in peripheral blood of the subjects in normal group and the patients in ischemic cerebral infarction group as well as the normal cultured SH-SY5Y cells(control group)and the cells in OGD model(OGD group).After transfecting SH-SY5Y cells with si-Myod1,pcDNA3.0-Myod1,si-SNHG15,pcDNA3.0-SNHG15、si-NC,Vector,miR-NC,and miR-24-3p mimics,the cells were treated with OGD,and then the SH-SY5Y cells were divided into control group,OGD group,OGD+Vector group,OGD+Myod1 group,OGD+si-NC group,OGD+si-Myod1 group,OGD+si-SNHG15 group,OGD+si-SNHG15+Vector group,OGD+si-SNHG15+Myod1 group,OGD+miR-NC group,OGD+miR-mimics group,OGD+miR-mimics+Vector group,and OGD+miR-mimics+SNHG15 group.CCK-8 method was used to detect the cell activities in various groups;5-ethynyl-2'-deoxyuridine(EdU)staining was used to detect the rates of EDU positive cells in various groups;the rates of TdT-mediated dUTP nick end labeling(TUNEL)positive cells in various groups were detected by TUNEL staining;Western blotting method was used to detect the expression levels of cleaved caspase-3,cleaved caspase-9,B-cell lymphoma 2(Bcl-2)and Bcl-2 associated X protein(Bax)proteins in the cells in various groups;the association between Myod1 and SNHG15 was evaluated by chromatin immunoprecipitate(CHIP);dual luciferase reporter gene experiment was used to evaluate the targeting relationships between Myod1 and SNHG15 as well as SNHG15 and miR-24-3p.Results:Compared with normal control group,the expression levels of Myod1 and SNHG15 mRNA in peripheral blood of the patients in ischemic cerebral infarction group were significantly increased(P<0.05).Compared with control group,the expression levels of Myod1 and SNHG15 mRNA in the SH-SY5Y cells in OGD group were significantly increased(P<0.05).Compared with OGD group,the cell activities and rates of EdU positive cells in OGD+Myod1 group at 48 and 72 h were decreased(P<0.01),and the rates of TUNEL positive cells were increased(P<0.05);the cell activities and rates of EdU positive cells in OGD+si-Myod1 group were increased(P<0.05),while the rates of TUNEL positive cells were decreased(P<0.01).Myod1 binded to the promoter sequence of SNHG15.SNHG15 could absorb miR-24-3p,and there were target relatronships between Myod1 and SNHG15 as well as SNHG15 and miR-24-3p.After SNHG15 knockdown,compared with OGD group,the cell activities and rates of EdU positive cells in OGD+si-SNHG15 group at 48 and 72 h were increased(P<0.01),and the rates of TUNEL positive cells were decreased(P<0.01),the expression levels of Bax,cleaved caspase-3 and cleaved caspase-9 proteins were decreased(P<0.01),and the expression levels of Bcl-2 protein were increased(P<0.01).Compared with OGD+si-SNHG15 group,the cell activities and rates of EdU positive cells in OGD+si-SNHG15+Myod1 group at 48 and 72 h were decreased(P<0.05),the rates of TUNEL positive cells were(P<0.05),the expression levels of Bax,cleaved caspase-3,and cleaved caspase-9 proteins were increased(P<0.05),and the expression levels of Bcl-2 were decreased(P<0.05).After over-expression of miR-24-3p and SNHG15,compared with OGD group,the cell activities and rates of EdU positive cells in OGD+miR-mimics group at 48 and 72 h were increased(P<0.01),the rates of TUNEL positive cells were significantly decreased(P<0.01),the protein expression levels of Bax,cleaved caspase-3 and cleaved caspase-9 were decreased(P<0.05),and the expression levels of Bcl-2 were increased(P<0.01).Compared with OGD+miR-mimics group,the cell activities and rates of EdU positive cells in OGD+miR-mimics+SNHG15 group at 48 and 72 h were decreased(P<0.05),and the rates of TUNEL positive cells were increased(P<0.05),the expression levels of Bax,cleaved caspase-3 and cleaved caspase-9 proteins were increased(P<0.05),and the expression levels of Bcl-2 protein were decreased(P<0.05).Conclusion:Myod1 can promote the proliferation inhibition and apoptosis of OGD-induced SH-SY5Y cells by binding to the SNHG15 promoter region and then absorbing miRNA-24.
5.Application and Practice of Drug Quantitative Scoring Table in the Temporary Drug Purchase of Our Hospital
Yue ZHAO ; Hongtao LIU ; Chaojun XUE ; Bingnan REN ; Wanjun BAI ; Zhanjun DONG
China Pharmacy 2019;30(11):1576-1580
OBJECTIVE: To standardize the management of temporary drug purchase, and to provide reference for drug selection in Hospital Pharmaceutical Administration and Drug Treatment Committee (Pharmaceutical Association). METHODS: Clinical pharmacists set up drug quantitative scoring table according to the 10 attributes of drugs as effectiveness, safety, economy, etc. 15 temporary purchased drugs submitted by departments in Oct. 2018 were graded according to the rules of the scoring table, and the evaluation results were fed back to Pharmaceutical Association. A retrospective evaluation of 20 temporary purchased drugs which were discussed at the Pharmaceutical Association from Jul. to Sept. 2018 was made according to previous approval model without using drug quantitative scoring table. The effect of pre-intervention was evaluated after using drug quantitative scoring table. RESULTS: Among 15 temporary purchased drugs, 2 of them scored below 60, and the unqualified rate was 13.3%. It suggested that 2 drugs could not be discussed at the meeting. Among 20 temporary purchased drugs that have been discussed at the meeting, 9 of them scored below 60, with the unqualified rate of 45.0%, suggesting that 9 drugs may have wasted the workload of the Pharmaceutical Association. CONCLUSIONS: Drug quantitative scoring table can play a pre-intervention role in the scoring of temporary purchased drugs to a certain extent. At the same time, the table can also be used as a relevant reference for hospital drug evaluation. It is helpful to optimize hospital drug use list and improve the level of rational drug use in clinic.
6.Use of Severe ADR-inducing Drugs in Special Population in Our Hospital Guided by the Detailed Quantitative Scoring Rules of Quick Guide for Drug Evaluation and Selection in Chinese Medical Institutions
Xiao LI ; Bo QIU ; Bingnan REN ; Zhanjun DONG
China Pharmacy 2021;32(17):2139-2149
OBJECTIVE:To promote the safe use of severe ADR-inducing drugs in special population in our hospital. METHODS:According to detailed quantitative scoring rules of Quick Guide for Drug Evaluation and Selection in Chinese Medical Institutions,comprehensive evaluation database of drugs in our hospital was established. Drugs with ADR rating or ADE general terminology standard rating of 1,2,3 and 4 under the "safety" dimension were obtained from the database. According to the difference of the incidence of ADR ,4 kinds of severe ADR-inducing drugs ,such as very common (incidence≥10%),common (incidence 1%-<10%),occasional(incidence 0.1%-<1%)and rare (incidence <0.1%),were obtained. According to the quantitative scores of these 4 kinds of drugs in six special groups ,such as children ,pregnant women ,lactating women ,the elderly,patients with abnormal liver function ,and patients with abnormal kidney function ,the feasibility for special population to use drugs that cause severe ADR was analyzed. RESULTS :Among 1 172 chemical drugs in drug comprehensive evaluation database of our hospital ,18,73,61,and 357 kinds can cause very common ,common,occasional and rare severe ADR , respectively. Among them ,the incidence of severe ADR caused by tumor drugs was high ,so it was necessary to pay close attention to the use of tumor drugs in special populations. Totally 173 kinds of drugs were prohibited for children because the instructions clearly showed organ toxicity ,cytotoxicity and there were no guidelines recommending their use in children ,so the clinical medication should be used with extraordinary caution. There were 278 and 228 drugs prohibited for pregnant women and lactating women,which were prohibited for pregnant or lactating period due to embryonic toxicity and reproductive toxicity. There were 13 prohibited drugs for the elderly ,most of which were specialized drugs. Five kinds of drugs were prohibited in patients with abnormal liver function and seven were prohibited in patients with abnormal kidney function ,most of which were tumor drugs with strong hepatorenal toxicity. CONCLUSIONS :Established quantitative score system can provide effective guidance for the safe use of severe ADR-inducing drugs among 6 special populations as children ,pregant women ,lactating women ,the elderly ,the patients with abnormal liver function and the patients with renal
7.Network meta-analysis of first-line treatments for metastatic urothelial carcinoma
Xuejia QIU ; Bingnan REN ; Lingzhi FANG ; Yufei LIAN ; Yupei WU ; Zhanjun DONG
China Pharmacy 2024;35(22):2815-2821
OBJECTIVE To systematically evaluate the effectiveness of different treatment regimens as first-line treatment for metastatic urothelial carcinoma (UC) using a network meta-analysis (NMA) approach. METHODS Electronic databases including PubMed, the Cochrane Library, Embase, Wanfang Data, CNKI, and VIP were searched for randomized controlled clinical trials (RCTs) on first-line treatment for metastatic UC from January 1, 2010 to January 31, 2024. After literature screening and data extraction, a risk of bias assessment of included studies was conducted. R software (version 4.3.2) was used to perform the NMA. RESULTS A total of 11 RCTs involving 14 treatment interventions were included. No significant differences were noted in objective response rate among groups, with the combination of pembrolizumab, gemcitabine and cisplatin having the highest probability of ranking first. Regarding progression-free survival (PFS) and overall survival (OS), no significant differences were observed among groups, while enfortumab vedotin combined with pembrolizumab showed a trend towards better PFS extension compared to gemcitabine combined with cisplatin [HR=0.45, 95%CI(0.20,1.06), P=0.049], and it had the highest probability of ranking first in both PFS and OS. CONCLUSIONS The combination of enfortumab vedotin and pembrolizumab may have an advantage in prolonging survival in the first-line treatments for metastatic UC.